ZA995321B - Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents

Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them.

Info

Publication number: ZA995321B
Authority: ZA; South Africa
Prior art keywords: alkyl; indan; compounds; preparation; pharmaceutical compositions
Prior art date: 1998-08-21

Application number

ZA9905321A

Other languages

English (en)

Inventor

Jean-Louis Peglion

Bertrand Goument

Mark Millan

Adrian Newman-Tancredi

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-21

Filing date

1999-08-20

Publication date

2000-02-22

1999-08-20 Application filed by Adir filed Critical Adir

2000-02-22 Publication of ZA995321B publication Critical patent/ZA995321B/xx

Links

YIAPLDFPUUJILH-UHFFFAOYSA-N indan-1-ol Chemical class C1=CC=C2C(O)CCC2=C1 YIAPLDFPUUJILH-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 3
150000002431 hydrogen Chemical class 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000003545 alkoxy group Chemical group 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical class 0.000 abstract 2
125000000623 heterocyclic group Chemical group 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000004385 trihaloalkyl group Chemical group 0.000 abstract 2
102100027499 5-hydroxytryptamine receptor 1B Human genes 0.000 abstract 1
101150050738 HTR1B gene Proteins 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229940126601 medicinal product Drugs 0.000 abstract 1
230000007170 pathology Effects 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

ZA9905321A 1998-08-21 1999-08-20 Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them. ZA995321B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9810601A FR2782515B1 (fr)	1998-08-21	1998-08-21	NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (1)

Publication Number	Publication Date
ZA995321B true ZA995321B (en)	2000-02-22

Family

ID=9529811

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9905321A ZA995321B (en)	1998-08-21	1999-08-20	Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them.

Country Status (18)

Country	Link
US (1)	US6153625A (de)
EP (1)	EP0982305B1 (de)
JP (1)	JP2000072748A (de)
CN (1)	CN1128144C (de)
AT (1)	ATE214064T1 (de)
AU (1)	AU747494B2 (de)
BR (1)	BR9903867A (de)
CA (1)	CA2280596A1 (de)
DE (1)	DE69900961T2 (de)
DK (1)	DK0982305T3 (de)
ES (1)	ES2172294T3 (de)
FR (1)	FR2782515B1 (de)
HU (1)	HUP9902784A3 (de)
NO (1)	NO317516B1 (de)
NZ (1)	NZ337362A (de)
PL (1)	PL194852B1 (de)
PT (1)	PT982305E (de)
ZA (1)	ZA995321B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0103647D0 (sv) *	2001-11-01	2001-11-01	Astrazeneca Ab	Therapeutic chromone compounds
SE0103646D0 (sv) *	2001-11-01	2001-11-01	Astrazeneca Ab	Therapeutic chroman compounds
NZ526699A (en) *	2001-01-16	2005-03-24	Astrazeneca Ab	8-amino derivatives and their use in treating migraine
MXPA03006250A (es) *	2001-01-16	2003-09-22	Astrazeneca Ab	Compuestos heterociclicos terapeuticos.
BR0206513A (pt) *	2001-01-16	2004-01-06	Astrazeneca Ab	Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos
DE10142661B4 (de) *	2001-08-31	2004-06-09	Aventis Pharma Deutschland Gmbh	Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142667B4 (de) *	2001-08-31	2004-06-09	Aventis Pharma Deutschland Gmbh	C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
DE10142662B4 (de) *	2001-08-31	2004-07-08	Aventis Pharma Deutschland Gmbh	Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
UY29892A1 (es) *	2005-11-04	2007-06-29	Astrazeneca Ab	Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
CN116283657B (zh) *	2023-02-22	2024-08-20	贵州大学	一种茚酮衍生物及其合成方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2681325B1 (fr) *	1991-09-16	1993-12-17	Fabre Medicament Pierre	Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
GB9318431D0 (en) *	1993-09-06	1993-10-20	Boots Co Plc	Therapeutic agents
FR2761358B1 (fr) *	1997-03-27	1999-05-07	Adir	Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

1998
- 1998-08-21 FR FR9810601A patent/FR2782515B1/fr not_active Expired - Fee Related
1999
- 1999-08-13 US US09/374,161 patent/US6153625A/en not_active Expired - Fee Related
- 1999-08-19 HU HU9902784A patent/HUP9902784A3/hu unknown
- 1999-08-19 JP JP11232097A patent/JP2000072748A/ja active Pending
- 1999-08-20 ZA ZA9905321A patent/ZA995321B/xx unknown
- 1999-08-20 EP EP99402092A patent/EP0982305B1/de not_active Expired - Lifetime
- 1999-08-20 CA CA002280596A patent/CA2280596A1/fr not_active Abandoned
- 1999-08-20 NO NO19994041A patent/NO317516B1/no unknown
- 1999-08-20 PT PT99402092T patent/PT982305E/pt unknown
- 1999-08-20 DK DK99402092T patent/DK0982305T3/da active
- 1999-08-20 CN CN99119425A patent/CN1128144C/zh not_active Expired - Fee Related
- 1999-08-20 BR BR9903867-6A patent/BR9903867A/pt not_active Application Discontinuation
- 1999-08-20 PL PL335012A patent/PL194852B1/pl not_active IP Right Cessation
- 1999-08-20 DE DE69900961T patent/DE69900961T2/de not_active Expired - Fee Related
- 1999-08-20 AU AU44637/99A patent/AU747494B2/en not_active Ceased
- 1999-08-20 ES ES99402092T patent/ES2172294T3/es not_active Expired - Lifetime
- 1999-08-20 AT AT99402092T patent/ATE214064T1/de not_active IP Right Cessation
- 1999-08-20 NZ NZ337362A patent/NZ337362A/xx unknown

Also Published As

Publication number	Publication date
DE69900961D1 (de)	2002-04-11
CN1128144C (zh)	2003-11-19
NO317516B1 (no)	2004-11-08
EP0982305A1 (de)	2000-03-01
HUP9902784A3 (en)	2001-03-28
EP0982305B1 (de)	2002-03-06
FR2782515B1 (fr)	2000-09-22
ES2172294T3 (es)	2002-09-16
ATE214064T1 (de)	2002-03-15
NO994041L (no)	2000-02-22
FR2782515A1 (fr)	2000-02-25
CN1250051A (zh)	2000-04-12
NZ337362A (en)	2000-04-28
PL335012A1 (en)	2000-02-28
DE69900961T2 (de)	2002-11-07
DK0982305T3 (da)	2002-06-24
JP2000072748A (ja)	2000-03-07
NO994041D0 (no)	1999-08-20
HUP9902784A2 (hu)	2000-12-28
PL194852B1 (pl)	2007-07-31
AU747494B2 (en)	2002-05-16
PT982305E (pt)	2002-07-31
HK1026212A1 (en)	2000-12-08
US6153625A (en)	2000-11-28
HU9902784D0 (en)	1999-10-28
CA2280596A1 (fr)	2000-02-21
AU4463799A (en)	2000-03-09
BR9903867A (pt)	2000-09-05

Publication	Publication Date	Title
SE9903998D0 (sv)	1999-11-03	New compounds
NZ505453A (en)	2002-11-26	Hypolipidemic benzothiazepine compounds
ATE296826T1 (de)	2005-06-15	Pyrazolo(1,5)pyridinderivate
DE60112609D1 (en)	2005-09-15	Pyrazolopyridine
PT1263724E (pt)	2005-09-30	Novos compostos
CO5180642A1 (es)	2002-07-30	Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion
TR200001973T2 (tr)	2001-01-22	11 ß-halojen-7alfa-ile ikame edilmiş-estratrienler, bu 11ß-halojen-7alfa-ile ikame edilmiş-estratrienleri içeren farmasötik terkiplerin üretimi için yöntem ve ilaç üretiminde kullanımları.
ATE316083T1 (de)	2006-02-15	Adamantanderivate
ATE300541T1 (de)	2005-08-15	Pyrazolopyridinderivate
SE9903997D0 (sv)	1999-11-03	New compounds
ATE233754T1 (de)	2003-03-15	Diphenyl-piperidin derivate
ES2036926A1 (es)	1993-06-01	"procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
HU9902784D0 (en)	1999-10-28	New indan-1-ol compounds, process for their preparation and pharmaceutical compositions containing them
DE69933885D1 (de)	2006-12-14	Triphenylbutenderivate zur behandlung von neurologischen störungen
AU2002357740A1 (en)	2003-06-23	Pyrazolo-pyridine derivatives as antiherpes agents
HUP9902199A1 (hu)	2000-06-28	Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítmények
DE60201074D1 (en)	2004-09-30	Pyrazolopyridinderivate
MXPA05010783A (es)	2005-12-12	Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos.
BG105923A (en)	2002-05-31	Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
SE9903996D0 (sv)	1999-11-03	New compounds
HUP9801451A2 (hu)	1999-02-01	Tetrahidroimidazo[2,1-a]izokinolin-származékok és ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk
IL70557A (en)	1987-11-30	4-(1-phenyl-1-hydroxypropyl)-resorcin derivatives,their preparation and pharmaceutical compositions containing them
ZA994817B (en)	2000-02-02	8H-thieno-[2,3-b]pyrrolizin-8-one compounds, a process for their preparation and pharmaceutical compositions containing them.
EE200200302A (et)	2003-06-16	Küllastumata 14,15-tsüklopropanoandrostaanid, nende valmistamise meetod ja neid ühendeid sisaldavadfarmatseutilised kompositsioonid